Free Trial

Pulmatrix (PULM) Competitors

Pulmatrix logo
$5.61 -0.41 (-6.81%)
Closing price 07/24/2025 04:00 PM Eastern
Extended Trading
$5.71 +0.10 (+1.78%)
As of 07/24/2025 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PULM vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Pulmatrix stock or one of its competitors? The main competitors of Pulmatrix include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Pulmatrix vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Pulmatrix (NASDAQ:PULM) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

180 Life Sciences has higher earnings, but lower revenue than Pulmatrix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Pulmatrix$1.92M10.66-$6.94M-$3.34-1.68

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Pulmatrix's score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
Pulmatrix Very Positive

11.8% of Pulmatrix shares are owned by institutional investors. 0.6% of Pulmatrix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

180 Life Sciences has a net margin of 0.00% compared to Pulmatrix's net margin of -122.46%. 180 Life Sciences' return on equity of 0.00% beat Pulmatrix's return on equity.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Pulmatrix -122.46%-94.97%-84.57%

Summary

180 Life Sciences beats Pulmatrix on 4 of the 7 factors compared between the two stocks.

Get Pulmatrix News Delivered to You Automatically

Sign up to receive the latest news and ratings for PULM and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PULM vs. The Competition

MetricPulmatrixMED IndustryMedical SectorNASDAQ Exchange
Market Cap$21.98M$3.05B$5.72B$9.47B
Dividend YieldN/A2.40%4.60%3.99%
P/E Ratio-1.6820.8627.9419.95
Price / Sales10.66317.05452.94100.82
Price / CashN/A43.2336.5558.97
Price / Book2.298.308.645.90
Net Income-$6.94M-$55.19M$3.24B$258.42M
7 Day Performance-11.44%5.81%3.69%2.11%
1 Month Performance-17.98%17.73%10.33%12.44%
1 Year Performance165.88%4.67%34.30%19.55%

Pulmatrix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PULM
Pulmatrix
0.2785 of 5 stars
$5.61
-6.8%
N/A+167.1%$21.98M$1.92M-1.6820Positive News
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A+11.8%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
-63.4%
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.12
+2.2%
N/AN/A$0.00$106.21K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.65
-7.3%
N/A-27.2%$0.00$585.60M0.004Positive News
Gap Up
AMPE
Ampio Pharmaceuticals
N/AN/AN/A+145.5%$0.00N/A0.0020
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+21.5%
N/AN/A$0.00$38.00M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.01
-3.4%
N/A-97.2%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.05
-29.9%
N/A-65.8%$0.00N/A0.008Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:PULM) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners